Previous close | 46.17 |
Open | 54.00 |
Bid | 37.40 |
Ask | 40.70 |
Strike | 450.00 |
Expiry date | 2025-01-17 |
Day's range | 46.17 - 54.00 |
Contract range | N/A |
Volume | |
Open interest | 98 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...